Phase II trial with ifosfamide in pancreatic cancer
- 1 January 1993
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (2) , 290
- https://doi.org/10.1016/0959-8049(93)90201-p
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Ifosfamide is an inactive substance in the treatment of pancreatic carcinomaCancer, 1989
- An EORTC gastrointestinal group phase II evaluation of epirubicin combined with ifosfamide in advanced adenocarcinoma of the pancreasEuropean Journal of Cancer and Clinical Oncology, 1989
- Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.Journal of Clinical Oncology, 1988
- Ifosfamide: an active drug in the treatment of adenocarcinoma of the pancreas.Journal of Clinical Oncology, 1985